FDA warns consumers against Tri-Methyl Xtreme muscle growth product

By Stephen DANIELLS

- Last updated on GMT

FDA warns consumers against Tri-Methyl Xtreme muscle growth product

Related tags: Anabolic steroids, Anabolic steroid, Fda

The FDA has issued a consumer warning to stop using Las Vegas-based Extreme Products Group’s Tri-Methyl Xtreme following reports of serious liver injury.

The product claims to contain anabolic steroids and is sold on the Internet and in some retail stores and gyms.

“Products marketed as supplements that contain anabolic steroids pose a real danger to consumers,”​ said Charles Lee, MD, a senior medical advisor in the FDA’s Center for Drug Evaluation and Research’s Office of Compliance. “Anabolic steroids may have a range of serious adverse effects on many organ systems, and the damage may be irreversible.”

The product is stated to contain anabolic agents methyl-stenbolone, Max LMG (a non-methylated prohormone), and epistane.

The FDA is conducting an investigation to identify the product’s manufacturer following adverse event reports from consumers; one each from California, New Jersey and Utah. No reports of death have been from use of the product.

In addition to potential liver injury, anabolic steroids may also cause other serious long-term consequences, including adverse effects on cholesterol levels; increased risk of heart attack and stroke; masculinization of women; shrinkage of the testicles; breast enlargement; infertility in males; and short stature in children, said the FDA.

Related topics: Regulation, Sports nutrition

Related news

Related products

show more

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars